ZTS
Zoetis Inc
NYSE: ZTS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$113.83
-2.42% today
Updated 2026-04-29
Market cap
$48.05B
P/E ratio
18.91
P/S ratio
5.08x
EPS (TTM)
$6.02
Dividend yield
1.71%
52W range
$113 – $170
Volume
3.8M
WallStSmart proprietary scores
64
out of 100
Grade: C+
Hold
Investment rating
5.3
Growth
C+7.0
Quality
B+10.0
Profitability
A+6.0
Valuation
B4/9
Piotroski F-Score
Moderate
3.1
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$149.65
+31.47%
12-Month target
$116.02
+1.92%
Intrinsic (DCF)
$160.64
Margin of safety
+19.90%
3 Strong Buy8 Buy9 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Altman Z 3.14 — safe zone
+ Profit margin 28.20% — above average
+ ROE 66.00% — strong efficiency
+ Free cash flow $732.00M — positive
+ 19.90% below intrinsic value
Risks
- Debt/equity 2.85x — high leverage
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $8.08B | $8.54B | $9.26B | $9.47B | $9.47B | $10.0B |
| Net income | $2.11B | $2.34B | $2.49B | $2.67B | $603.00M | — |
| EPS | — | — | — | — | $6.02 | $7.08 |
| Free cash flow | $1.33B | $1.62B | $2.30B | $2.28B | $732.00M | — |
| Profit margin | 26.16% | 27.43% | 26.86% | 28.23% | 28.20% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-10 | SARBAUGH, KEITH | Buy | 231 | $39.64 |
| 2026-04-10 | PECK, KRISTIN C | Buy | 2,777 | $39.64 |
| 2026-04-10 | LAGANO, ROXANNE | Buy | 551 | $39.64 |
Peer comparison
Smart narrative
Zoetis Inc trades at $113.83. representing a P/E of 18.91x trailing earnings. Our Smart Value Score of 64/100 indicates the stock is good. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 3.14, it sits in the safe zone. TTM revenue stands at $9.47B. with profit margins at 28.20%. Our DCF model estimates intrinsic value at $160.64.
Frequently asked questions
What is Zoetis Inc's stock price?
Zoetis Inc (ZTS) trades at $113.83.
Is Zoetis Inc overvalued?
Smart Value Score 64/100 (Grade C+, Hold). DCF value $160.64.
What is the price target of Zoetis Inc (ZTS)?
The analyst target price is $149.65, representing +31.5% upside from the current price of $113.83.
What is the intrinsic value of Zoetis Inc (ZTS)?
Based on our DCF model, intrinsic value is $160.64, a +19.9% margin of safety versus $113.83.
What is the future stock price of ZTS by 2030?
Our research-backed model estimates Zoetis Inc could reach $330.23 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is Zoetis Inc's revenue?
TTM revenue is $9.47B.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
3.14 — safe zone.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio5.08x
ROE66.00%
Beta0.97
50D MA$120.40
200D MA$132.58
Shares out0.42B
Float0.42B
Short ratio—
Avg volume3.8M
Performance
1 week-1.92%
1 month-3.71%
3 months-6.48%
YTD-9.53%
1 year—
3 years—
5 years—